 United Therapeutics Corporation NASDAQ:UTHR Q2 2022 Results Conference Call August 3, 2022 9:00 AM ET Company Participants Dewey Steadman - Head, IR Dr. Martine Rothblatt - Chairperson, CEO Michael Benkowitz - President, COO Dr. Leigh Peterson - SVP, Product Development Pat Poisson - EVP, Technical Operations Conference Call Participants Hartaj Singh - Oppenheimer Co Eun Yang - Jefferies Joe Thome - Cowen Jessica Fye - JPMorgan Andreas Argyrides - Wedbush Securities Operator Good morning, and welcome to the United Therapeutics Corporation Second Quarter 2022 Earnings Webcast. My name is Dennis, and I will be your conference operator today. 